U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.904G>A (p.Gly302Arg) AND Li-Fraumeni syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 25, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001352238.7

Allele description [Variation Report for NM_000546.6(TP53):c.904G>A (p.Gly302Arg)]

NM_000546.6(TP53):c.904G>A (p.Gly302Arg)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.904G>A (p.Gly302Arg)
HGVS:
  • NC_000017.11:g.7673716C>T
  • NG_017013.2:g.18835G>A
  • NM_000546.6:c.904G>AMANE SELECT
  • NM_001126112.3:c.904G>A
  • NM_001126113.3:c.904G>A
  • NM_001126114.3:c.904G>A
  • NM_001126115.2:c.508G>A
  • NM_001126116.2:c.508G>A
  • NM_001126117.2:c.508G>A
  • NM_001126118.2:c.787G>A
  • NM_001276695.3:c.787G>A
  • NM_001276696.3:c.787G>A
  • NM_001276697.3:c.427G>A
  • NM_001276698.3:c.427G>A
  • NM_001276699.3:c.427G>A
  • NM_001276760.3:c.787G>A
  • NM_001276761.3:c.787G>A
  • NP_000537.3:p.Gly302Arg
  • NP_001119584.1:p.Gly302Arg
  • NP_001119585.1:p.Gly302Arg
  • NP_001119586.1:p.Gly302Arg
  • NP_001119587.1:p.Gly170Arg
  • NP_001119588.1:p.Gly170Arg
  • NP_001119589.1:p.Gly170Arg
  • NP_001119590.1:p.Gly263Arg
  • NP_001263624.1:p.Gly263Arg
  • NP_001263625.1:p.Gly263Arg
  • NP_001263626.1:p.Gly143Arg
  • NP_001263627.1:p.Gly143Arg
  • NP_001263628.1:p.Gly143Arg
  • NP_001263689.1:p.Gly263Arg
  • NP_001263690.1:p.Gly263Arg
  • LRG_321:g.18835G>A
  • NC_000017.10:g.7577034C>T
  • NM_000546.4:c.904G>A
Protein change:
G143R
Links:
dbSNP: rs863224686
NCBI 1000 Genomes Browser:
rs863224686
Molecular consequence:
  • NM_000546.6:c.904G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.904G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.904G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.904G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126115.2:c.508G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126116.2:c.508G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126117.2:c.508G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.787G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.787G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.787G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276697.3:c.427G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276698.3:c.427G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276699.3:c.427G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.787G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.787G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Li-Fraumeni syndrome (LFS)
Synonyms:
Sarcoma family syndrome of Li and Fraumeni
Identifiers:
MONDO: MONDO:0018875; MedGen: C0085390; OMIM: PS151623

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001546775Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Mar 25, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.

Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C.

Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8424-9. Epub 2003 Jun 25.

PubMed [citation]
PMID:
12826609
PMCID:
PMC166245

Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.

Zerdoumi Y, Lanos R, Raad S, Flaman JM, Bougeard G, Frebourg T, Tournier I.

Hum Mol Genet. 2017 Jul 15;26(14):2591-2602. doi: 10.1093/hmg/ddx106. Erratum in: Hum Mol Genet. 2017 Jul 15;26(14):2812. doi: 10.1093/hmg/ddx165.

PubMed [citation]
PMID:
28369373
PMCID:
PMC5886078
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001546775.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been reported not to substantially affect TP53 protein function (PMID: 12826609). This variant has been observed in individual(s) with breast cancer (PMID: 28369373). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 302 of the TP53 protein (p.Gly302Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024